Hyperglycemia in thrombolysed acute ischemic stroke patients

International Journal of Stroke

Volumn 6, Issue 3, 2011, Pages 278-278

  Poppe, Alexandre Y ^a   Hill, Michael D ^b  

^a NOTRE DAME HOSPITAL   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; DISEASE ASSOCIATION; HUMAN; HYPERGLYCEMIA; LETTER; PRIORITY JOURNAL; STROKE PATIENT;

BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; COHORT STUDIES; HOSPITAL MORTALITY; HUMANS; HYPERGLYCEMIA; PLASMINOGEN ACTIVATORS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 79955780102     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2011.00586.x     Document Type: Letter

References (6)

1. Meurer WJ, Scott PA, Caveney AF et al. Lack of association between hyperglycaemia at arrival and clinical outcomes in acute stroke patients treated with tissue plasminogen activator. Int J Stroke 2010; 5:163-6.
2. Demchuk AM, Morgenstern LB, Krieger DW et al. Serum glucose and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke 1999; 30:34-9.
3. Bruno A, Levine SR, Frankel MR et al. Admission glucose level and clinical outcomes in the NINDS rt-PA stroke trial. Neurology 2002; 58:669-74.
4. Alvarez-Sabín J, Molina CA, Montaner J et al. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients. Stroke 2003; 34:1235-41.
5. Poppe AY, Majumdar SR, Jeerakathil T et al. Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis. Diabetes Care 2009; 32:617-22.
6. Uyttenboogaart M, Koch MW, Stewart RE, Vroomen PC, Luijckx GJ, De Keyser J. Moderate hyperglycaemia is associated with favourable outcome in acute lacunar stroke. Brain 2007; 130:1626-30.